Pfizer, Inc, United States
Pfizer Inc. (Employment)
Preliminary Results from HERO-together: A Post-emergency Use Authorization Observational Cohort Study to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine in US Healthcare Workers and Community Members
Sunday, August 28, 20222:30 PM – 2:45 PM CEST